There are few Alzheimer's drugs for people with symptoms—and nothing for presymptomatic people. The leading drugs are expensive antibody infusions that clear out most of the visible deposits, called amyloid, but don't slow the degeneration of neurons. These have shown only a modest ability to ...
Alzheimer’s disease (AD) is a progressive, clinically heterogeneous, age-sensitive neurodegenerative disease, characterised by often escalating impairments of memory and other cognitive functions together with associated changes in personality and behaviour [1,2,3]. Amyloid plaques and neurofibrillary tangl...
There is certainly a good reason to believe that daytime sleepiness-as in the Alzheimer's study-can be a marker of an underlying condition. For most people,napping during the day is mainly a sign that you are not getting enough sleep at night,says Dr Neil Stanley, a sl...
The Alzheimer's Association also advocates for a pilot project of this kind, which could be adopted "Medicare-wide" if it's shown to beneficial and cost-effective, said Matthew Baumgart, the association's vice president of health policy. Under a model proposed by the association, comprehensive...
There is certainly a good reason to believe that daytime sleepiness-as in the Alzheimer's study-can be a marker of an underlying condition. For most people, napping during the day is mainly a sign that you are not getting enough sleep at night, says Dr Neil Stanley, a...